Edition:
India

People: Galapagos NV (GLPG.AS)

GLPG.AS on Amsterdam Stock Exchange

144.10EUR
18 Oct 2019
Change (% chg)

€-3.60 (-2.44%)
Prev Close
€147.70
Open
€146.05
Day's High
€147.00
Day's Low
€143.45
Volume
119,255
Avg. Vol
387,489
52-wk High
€171.20
52-wk Low
€74.48

Mummery, Christine 

Dr. Christine Mummery, Ph.D. has been Non-Executive Independent Director of Galapagos NV since November 4, 2015. As of 2008, Dr. Christine Mummery is Professor of Developmental Biology and Chair of the Department of Anatomy and Embryology at the Leiden University Medical Centre (LUMC) in The Netherlands. After her PhD in BioPhysics at London University, she was postdoctoral fellow at the Hubrecht Institute in Utrecht, later also staff member and group leader. She became Professor at the Interuniversity Cardiology of the Netherlands (ICIN) at the University Medical Centre Utrecht in 2002. In 2007, she was a joint Harvard Stem Cell Institute/Radcliffe fellow at Harvard and Massachusetts General Hospital at the time human induced pluripotent stem cells were being developed and was the first to derive iPSC lines from patients. Her primary research focus is currently the development and use of stem cells in cardiovascular development and disease. She served on the Ethical Councils of the Ministry of Health, is member of the Royal Netherlands Academy of Arts and Sciences (KNAW), editor in chief/editorial board member of several journals, former board member of ISSCR and past-president of the International Society of Differentiation. In addition, she chairs the executive board of the hDMT Institute for human Organ and Disease Model technologies, a non-profit R&D institute of which the LUMC is a founding partner. She is a review committee member of the European Research Council, the Leducq Foundation, the Wellcome Trust (ad hoc) and the Heineken Jury Prize (KNAW).

Basic Compensation

Total Annual Compensation, EUR 41,000
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 41,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --